sofosbuvir has been researched along with Congenital Zika Syndrome in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Bernatchez, JA; Li, J; Li, R; Luan, Y; Siqueira-Neto, JL; Tran, LT | 1 |
| Amendoeira, FC; Bortolini, RG; Coelho, EF; da Fonseca, LB; da Silva, LSFV; da Silveira, GPE; de Araújo, JFGM; de Assis Nascimento, V; de Azevedo da Silva, AC; Dias da Silva, DM; Dos Santos, VGV; Estrela Marins, RCE; Pereira, HM; Pinto, DP; Souza, TML; Vilhena, LS | 1 |
| Chahroudi, A; Kovacs-Balint, Z; Mavigner, M; Medina, A; Raper, J; Richardson, R; Rusnak, R; Sanchez, M; Schoof, N; Suthar, M; Zimmerman, MG | 1 |
| Alves, AMB; Andrade, MCR; Bentes, GA; Bottino, FO; Castro, MP; Fonseca, LB; Freire, MS; Gardinali, NR; Kugelmeier, T; Lima, SMB; Linhares, JHR; Lopes, CAA; Marchevsky, RS; Melgaço, JG; Miranda, EH; Moran, J; Motta, MCVA; Nudelman, RF; Oliveira, JM; Pelajo-Machado, M; Perea, JAS; Pereira, HM; Pinto, DP; Pinto, MA; Salvador Castro Faria, SB; Sarges, K; Schmidt-Chanasit, J; Silva, ACA; Silva, MCC; Silva, SA; Soares-Bezerra, RJ; Soriano, A; Souza, TML; Trindade, GF; Vilhena, LS | 1 |
| Barbosa-Lima, G; Bozza, FA; Bozza, PT; Brüning, K; Campanati, L; de Castro Faria Neto, HC; Ferreira, AC; Mattos, M; Reis, PA; Sacramento, C; Silva, PP; Souza, TML; Tanuri, A; Vieira, YR; Zaverucha-do-Valle, C | 1 |
| Goebel, S; Kalkeri, R; Koide, F; Ptak, R; Snyder, B | 1 |
| Beltrão-Braga, PCB; de A Zanotto, PM; Fernandes, IR; LaRock, CN; Macia, A; Mesci, P; Muotri, AR; Nizet, V; Suarez, NA; Tejwani, L | 1 |
| Bullard-Feibelman, KM; Diamond, MS; Geiss, BJ; Govero, J; Salazar, V; Veselinovic, M; Zhu, Z | 1 |
| Abrantes, JL; Barbosa-Lima, G; Bastos, MM; Boechat, N; Bozza, FA; Bozza, PT; Brüning, K; de Filippis, AM; de Freitas, CS; de Mello Volotão, E; de Melo, GR; Ferreira, AC; Fintelman-Rodrigues, N; Hoelz, LV; Leomil, L; Loiola, EC; Marttorelli, A; Miranda, M; Nunes, EP; Rehen, SK; Rocha, N; Sacramento, CQ; Souza, TM; Thompson, FL; Trindade, P; Tschoeke, DA; Vieira, YR | 1 |
1 review(s) available for sofosbuvir and Congenital Zika Syndrome
| Article | Year |
|---|---|
Drugs for the Treatment of Zika Virus Infection.
Topics: Animals; Antiviral Agents; Drug Development; Drug Discovery; Humans; Viral Vaccines; Zika Virus; Zika Virus Infection | 2020 |
1 trial(s) available for sofosbuvir and Congenital Zika Syndrome
| Article | Year |
|---|---|
Development and validation of LC-MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS-331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika.
Topics: Animals; Chromatography, Liquid; Humans; Limit of Detection; Plasma; Reproducibility of Results; Sofosbuvir; Tandem Mass Spectrometry; Zika Virus; Zika Virus Infection | 2023 |
7 other study(ies) available for sofosbuvir and Congenital Zika Syndrome
| Article | Year |
|---|---|
Treatment with sofosbuvir attenuates the adverse neurodevelopmental consequences of Zika virus infection in infant rhesus macaques.
Topics: Animals; Antiviral Agents; Macaca mulatta; Sofosbuvir; Zika Virus; Zika Virus Infection | 2023 |
Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeys.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Brazil; Female; Infectious Disease Transmission, Vertical; Macaca mulatta; Pregnancy; Pregnancy Complications, Infectious; Sofosbuvir; Translational Research, Biomedical; Viremia; Zika Virus; Zika Virus Infection | 2020 |
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae.
Topics: Animals; Animals, Newborn; Antiviral Agents; Chlorocebus aethiops; Memory; Mice; Reflex, Righting; RNA, Viral; Sofosbuvir; Vero Cells; Virus Replication; Zika Virus; Zika Virus Infection | 2017 |
Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and β) against Zika virus.
Topics: Africa; Antiviral Agents; Asia; Cell Line, Tumor; Cytoprotection; Female; Fluorescent Antibody Technique; Hepatocytes; Humans; Interferon-alpha; Interferon-beta; Pregnancy; Proof of Concept Study; Sofosbuvir; Zika Virus; Zika Virus Infection | 2018 |
Modeling neuro-immune interactions during Zika virus infection.
Topics: Cell Line; Humans; Induced Pluripotent Stem Cells; Microglia; Models, Biological; Neural Stem Cells; Sofosbuvir; Zika Virus; Zika Virus Infection | 2018 |
The FDA-approved drug sofosbuvir inhibits Zika virus infection.
Topics: Administration, Oral; Animals; Antiviral Agents; Cell Line; Drug Approval; Drug Evaluation, Preclinical; Humans; Mice; Sofosbuvir; United States; United States Food and Drug Administration; Zika Virus; Zika Virus Infection | 2017 |
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication.
Topics: Antiviral Agents; Cell Line; Cell Survival; DNA-Directed RNA Polymerases; Genome, Viral; Humans; Mutation; Sofosbuvir; Viral Proteins; Virus Replication; Zika Virus; Zika Virus Infection | 2017 |